| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 SENP1 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 PRPF8 USP17L6P USP17L22 USP17L15 USP17L8 | 5.50e-19 | 137 | 300 | 24 | GO:0019783 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 PRPF8 USP17L6P USP17L22 USP17L15 USP17L8 | 7.91e-19 | 124 | 300 | 23 | GO:0101005 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.88e-18 | 114 | 300 | 22 | GO:0004843 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 SENP1 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 CAPN11 USP17L6P USP17L22 USP17L15 USP17L8 | 1.64e-15 | 192 | 300 | 24 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 LVRN USP34 USP17L21 RELN TRABD2B USP17L1 USP17L20 USP17L19 F7 USP20 USP17L18 SENP1 USP17L17 PARL USP17L3 MMP14 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 CPE PRPF8 CAPN11 USP17L6P KDM8 USP17L22 USP17L15 USP17L8 | 1.27e-09 | 654 | 300 | 33 | GO:0008233 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.46e-07 | 28 | 300 | 7 | GO:0051959 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.74e-07 | 18 | 300 | 6 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.13e-06 | 37 | 300 | 7 | GO:0045505 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.82e-06 | 16 | 300 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | type I interferon receptor binding | 3.95e-06 | 17 | 300 | 5 | GO:0005132 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.24e-05 | 21 | 300 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.60e-05 | 70 | 300 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK4 TBC1D5 TBC1D2B GMIP CHM ARHGEF17 SBF1 HPS1 PLCB1 SIPA1L2 PREX1 TNS3 ARAP2 DOCK1 P2RY12 KALRN RIC8B LLGL2 ARAP3 | 2.59e-04 | 507 | 300 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK4 TBC1D5 TBC1D2B GMIP CHM ARHGEF17 SBF1 HPS1 PLCB1 SIPA1L2 PREX1 TNS3 ARAP2 DOCK1 P2RY12 KALRN RIC8B LLGL2 ARAP3 | 2.59e-04 | 507 | 300 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.80e-04 | 39 | 300 | 5 | GO:0070325 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 3.73e-04 | 10 | 300 | 3 | GO:0001849 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.15e-04 | 118 | 300 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 4.46e-04 | 43 | 300 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | U5 snRNA binding | 6.68e-04 | 3 | 300 | 2 | GO:0030623 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 8.59e-04 | 13 | 300 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK4 TBC1D5 TBC1D2B GMIP CHM PLCB1 SIPA1L2 PREX1 ARAP2 DOCK1 LLGL2 ARAP3 | 1.11e-03 | 279 | 300 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 1.32e-03 | 4 | 300 | 2 | GO:0004052 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.24e-18 | 125 | 297 | 22 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 SENP1 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.04e-17 | 144 | 297 | 23 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 BIRC6 USP20 USP17L18 UBE4A SENP1 USP17L17 USP17L3 HECTD1 USP17L13 USP17L4 TRIM2 USP17L2 DET1 USP17L12 NEDD4L USP17L11 USP17L24 USP17L5 USP17L10 FBH1 KLHL36 MTOR KLHL15 USP17L6P USP17L22 HERC4 USP17L15 USP17L8 NSMCE4A | 1.43e-06 | 1009 | 297 | 35 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 BIRC6 MAP3K12 USP20 USP17L18 UBE4A SENP1 USP17L17 USP17L3 HECTD1 USP17L13 USP17L4 TRIM2 USP17L2 DET1 USP17L12 NEDD4L USP17L11 USP17L24 USP17L5 USP17L10 FBH1 KLHL36 MTOR KLHL15 USP17L6P USP17L22 HERC4 USP17L15 USP17L8 NSMCE4A | 2.20e-06 | 1074 | 297 | 36 | GO:0043687 |
| GeneOntologyBiologicalProcess | forebrain development | EPHB2 KIF21B RELN AXL EXT1 CHRNB2 EFHC1 SYNE2 PLCB1 DNAH5 FOXP2 P2RY12 DYNC2H1 SKI OGDH TH HOOK3 CELF1 IFT88 LRP2 LRP6 ROBO2 | 2.70e-06 | 489 | 297 | 22 | GO:0030900 |
| GeneOntologyBiologicalProcess | telencephalon development | EPHB2 KIF21B RELN EXT1 EFHC1 SYNE2 PLCB1 DNAH5 FOXP2 P2RY12 SKI OGDH TH CELF1 IFT88 LRP6 ROBO2 | 7.13e-06 | 332 | 297 | 17 | GO:0021537 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.01e-05 | 21 | 297 | 5 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 2.03e-05 | 24 | 297 | 5 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 4.48e-05 | 28 | 297 | 5 | GO:0042501 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 6.25e-05 | 48 | 297 | 6 | GO:0043277 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | CATSPERD FSIP2 EFHC1 DNAH5 DNAH8 ZMYND12 DNAH3 DYNC2H1 APOB IFT88 CFAP97D1 DNAH11 | 7.07e-05 | 215 | 297 | 12 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | CATSPERD FSIP2 EFHC1 DNAH5 DNAH8 ZMYND12 DNAH3 DYNC2H1 APOB IFT88 CFAP97D1 DNAH11 | 7.07e-05 | 215 | 297 | 12 | GO:0001539 |
| GeneOntologyBiologicalProcess | natural killer cell activation | 7.87e-05 | 124 | 297 | 9 | GO:0030101 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 9.26e-05 | 99 | 297 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 9.95e-05 | 100 | 297 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB2 RELN TBC1D5 TBC1D2B PLXND1 PLEKHM1 CHRNB2 LRIG2 PTPRO SYNE2 PREX1 USP17L2 NEDD4L P2RY12 KALRN SYNE1 NLGN1 CRP ABHD17B IFT88 MTOR TENM1 LRP1 LRP6 MACF1 ROBO2 EPHA7 | 1.01e-04 | 846 | 297 | 27 | GO:0120035 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.03e-04 | 75 | 297 | 7 | GO:0045109 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 1.03e-04 | 75 | 297 | 7 | GO:0021885 | |
| GeneOntologyBiologicalProcess | cilium movement | CATSPERD CFAP100 FSIP2 DNAH5 DNAH8 DYNC1H1 ZMYND12 DNAH3 DYNC2H1 APOB IFT88 CFAP97D1 DNAH11 | 1.13e-04 | 261 | 297 | 13 | GO:0003341 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPHB2 TBC1D5 TBC1D2B PLEKHM1 CEP350 CFAP100 FSIP2 CLCN4 PTPRO SYNE2 CFAP161 DNAH5 DNAH8 ZMYND12 USP17L2 P2RY12 DYNC2H1 SYNE1 NLGN1 IFT88 CFAP97D1 MTOR TENM1 | 1.16e-04 | 670 | 297 | 23 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB2 RELN TBC1D5 TBC1D2B PLXND1 PLEKHM1 CHRNB2 LRIG2 PTPRO SYNE2 PREX1 USP17L2 NEDD4L P2RY12 KALRN SYNE1 NLGN1 CRP ABHD17B IFT88 MTOR TENM1 LRP1 LRP6 MACF1 ROBO2 EPHA7 | 1.39e-04 | 863 | 297 | 27 | GO:0031344 |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.43e-04 | 134 | 297 | 9 | GO:0003279 | |
| GeneOntologyBiologicalProcess | cell projection assembly | EPHB2 TBC1D5 TBC1D2B PLEKHM1 CEP350 CFAP100 FSIP2 CLCN4 PTPRO SYNE2 CFAP161 DNAH5 DNAH8 ZMYND12 USP17L2 P2RY12 DYNC2H1 SYNE1 NLGN1 IFT88 CFAP97D1 MTOR TENM1 | 1.60e-04 | 685 | 297 | 23 | GO:0030031 |
| GeneOntologyBiologicalProcess | head development | EPHB2 KIF21B RELN AXL NAPA PFAS EXT1 CHRNB2 EFHC1 SYNE2 PLCB1 MMP14 DNAH5 NIPBL FOXP2 P2RY12 DYNC2H1 SKI OGDH TH HOOK3 CELF1 IFT88 LRP2 LRP6 ROBO2 FAIM2 EPHA7 | 1.63e-04 | 919 | 297 | 28 | GO:0060322 |
| GeneOntologyBiologicalProcess | external genitalia morphogenesis | 2.07e-04 | 2 | 297 | 2 | GO:0035261 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | CATSPERD FSIP2 DNAH5 DNAH8 ZMYND12 DNAH3 DYNC2H1 APOB IFT88 CFAP97D1 DNAH11 | 2.45e-04 | 210 | 297 | 11 | GO:0060294 |
| GeneOntologyBiologicalProcess | cardiac chamber development | MYH7 PLXND1 ACVR1 HECTD1 CPE IFT88 LRP1 LRP2 LRP6 ROBO2 DNAH11 | 2.66e-04 | 212 | 297 | 11 | GO:0003205 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | EPHB2 TBC1D5 TBC1D2B PLEKHM1 SYNE2 USP17L2 P2RY12 SYNE1 NLGN1 IFT88 MTOR TENM1 | 2.69e-04 | 248 | 297 | 12 | GO:0120032 |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 2.77e-04 | 213 | 297 | 11 | GO:0045807 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | EPHB2 TBC1D5 TBC1D2B PLEKHM1 SYNE2 USP17L2 P2RY12 SYNE1 NLGN1 IFT88 MTOR TENM1 | 3.00e-04 | 251 | 297 | 12 | GO:0060491 |
| GeneOntologyBiologicalProcess | brain development | EPHB2 KIF21B RELN AXL NAPA EXT1 CHRNB2 EFHC1 SYNE2 PLCB1 DNAH5 NIPBL FOXP2 P2RY12 DYNC2H1 SKI OGDH TH HOOK3 CELF1 IFT88 LRP2 LRP6 ROBO2 FAIM2 EPHA7 | 3.09e-04 | 859 | 297 | 26 | GO:0007420 |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 3.29e-04 | 42 | 297 | 5 | GO:0002323 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 3.57e-04 | 24 | 297 | 4 | GO:0031290 | |
| GeneOntologyCellularComponent | leading edge membrane | APC2 IFIT5 LAMP5 PLXND1 ADGRV1 BMX KCNH1 SYNE2 PLCG2 USH2A GRIA2 MACF1 ROBO2 MTMR9 GABRA1 | 4.04e-07 | 210 | 300 | 15 | GO:0031256 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 EPHX1 SPTLC3 USP17L21 SPAST USP17L1 USP17L20 SRP9 EXT1 USP17L19 USP17L18 SORT1 CLCN4 SBF1 USP17L17 CANT1 SYNE2 USP17L3 LPGAT1 USP17L13 AKAP6 USP17L4 USP17L2 ERO1B USP17L12 USP17L11 SYNE1 USP17L5 USP17L10 APOB TMEM43 NBAS ZDHHC20 MTOR DHRS7C IRAG2 USP17L6P UGT2B11 USP17L22 USP17L15 USP17L8 | 2.95e-06 | 1327 | 300 | 41 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 EPHX1 SPTLC3 USP17L21 SPAST USP17L1 USP17L20 SRP9 EXT1 USP17L19 USP17L18 SORT1 CLCN4 SBF1 USP17L17 CANT1 SYNE2 USP17L3 LPGAT1 USP17L13 AKAP6 USP17L4 USP17L2 ERO1B USP17L12 USP17L11 USP17L5 USP17L10 APOB TMEM43 NBAS ZDHHC20 MTOR DHRS7C IRAG2 USP17L6P UGT2B11 USP17L22 USP17L15 USP17L8 | 3.83e-06 | 1293 | 300 | 40 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 EPHX1 SPTLC3 USP17L21 SPAST USP17L1 USP17L20 SRP9 EXT1 USP17L19 USP17L18 SORT1 CLCN4 SBF1 USP17L17 CANT1 SYNE2 USP17L3 LPGAT1 USP17L13 AKAP6 USP17L4 USP17L2 ERO1B USP17L12 USP17L11 USP17L5 USP17L10 APOB TMEM43 NBAS ZDHHC20 MTOR DHRS7C IRAG2 USP17L6P UGT2B11 USP17L22 USP17L15 USP17L8 | 4.28e-06 | 1299 | 300 | 40 | GO:0098827 |
| GeneOntologyCellularComponent | dynein complex | 1.20e-04 | 54 | 300 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | cell leading edge | RAPH1 TRPM7 APC2 IFIT5 LAMP5 PLXND1 ADGRV1 BMX PTPRO KCNH1 SYNE2 PLCG2 USH2A GRIA2 ARAP3 MACF1 ROBO2 MTMR9 GABRA1 | 1.22e-04 | 500 | 300 | 19 | GO:0031252 |
| GeneOntologyCellularComponent | neuron projection membrane | 1.77e-04 | 82 | 300 | 7 | GO:0032589 | |
| GeneOntologyCellularComponent | cell projection membrane | APC2 IFIT5 LAMP5 PLXND1 ADGRV1 BMX KCNH1 SYNE2 PLCG2 USH2A P2RY12 GRIA2 LRP2 MACF1 ROBO2 MTMR9 GABRA1 | 1.79e-04 | 431 | 300 | 17 | GO:0031253 |
| GeneOntologyCellularComponent | dendrite | EPHB2 KIF21B RELN LAMP5 SORT1 KCND1 PTPRO KCNH1 IGSF9 C4A C4B PREX1 SYNE1 PCLO GRIA2 CPE NLGN1 CNNM1 TH ABHD17B MTOR LRP1 LRP2 GABRA1 EPHA7 | 6.70e-04 | 858 | 300 | 25 | GO:0030425 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | CHRNB2 PTPRO KCNH1 GRIA2 NLGN1 ABHD17B LRP1 ROBO2 GABRA1 EPHA7 | 6.79e-04 | 201 | 300 | 10 | GO:0099634 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 KIF21B RELN LAMP5 SORT1 KCND1 PTPRO KCNH1 IGSF9 C4A C4B PREX1 SYNE1 PCLO GRIA2 CPE NLGN1 CNNM1 TH ABHD17B MTOR LRP1 LRP2 GABRA1 EPHA7 | 6.92e-04 | 860 | 300 | 25 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 KIF21B RELN TRPM7 LAMP5 SORT1 EFHC1 KCND1 PTPRO KCNH1 IGSF9 C4A C4B USH2A PREX1 DYNC1H1 KALRN SYNE1 PCLO GRIA2 APOB CPE NLGN1 CNNM1 TH ABHD17B MTOR LRP1 LRP2 LRP6 GABRA1 EPHA7 | 8.29e-04 | 1228 | 300 | 32 | GO:0036477 |
| GeneOntologyCellularComponent | growth cone | KIF21B LAMP5 MAP3K12 LRIG2 PTPRO PREX1 PCLO GRIA2 CRP LRP1 LRP2 | 8.70e-04 | 245 | 300 | 11 | GO:0030426 |
| GeneOntologyCellularComponent | site of polarized growth | KIF21B LAMP5 MAP3K12 LRIG2 PTPRO PREX1 PCLO GRIA2 CRP LRP1 LRP2 | 1.13e-03 | 253 | 300 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | USH2 complex | 1.21e-03 | 4 | 300 | 2 | GO:1990696 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 5.68e-24 | 16 | 297 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 5.68e-24 | 16 | 297 | 14 | IPR006861 |
| Domain | UCH | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 6.12e-20 | 71 | 297 | 20 | PF00443 |
| Domain | USP_2 | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 6.12e-20 | 71 | 297 | 20 | PS00973 |
| Domain | USP_dom | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 8.35e-20 | 72 | 297 | 20 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 8.35e-20 | 72 | 297 | 20 | IPR001394 |
| Domain | USP_3 | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 8.35e-20 | 72 | 297 | 20 | PS50235 |
| Domain | USP_CS | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 3.34e-19 | 66 | 297 | 19 | IPR018200 |
| Domain | USP_1 | USP17L7 USP34 USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 1.16e-18 | 70 | 297 | 19 | PS00972 |
| Domain | ATPase_dyneun-rel_AAA | 4.15e-08 | 14 | 297 | 6 | IPR011704 | |
| Domain | MT | 4.15e-08 | 14 | 297 | 6 | PF12777 | |
| Domain | AAA_8 | 4.15e-08 | 14 | 297 | 6 | PF12780 | |
| Domain | AAA_5 | 4.15e-08 | 14 | 297 | 6 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.15e-08 | 14 | 297 | 6 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.15e-08 | 14 | 297 | 6 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.15e-08 | 14 | 297 | 6 | IPR013602 | |
| Domain | DHC_N2 | 4.15e-08 | 14 | 297 | 6 | PF08393 | |
| Domain | DHC_N1 | 5.30e-08 | 8 | 297 | 5 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.30e-08 | 8 | 297 | 5 | IPR013594 | |
| Domain | DHC_fam | 6.82e-08 | 15 | 297 | 6 | IPR026983 | |
| Domain | Dynein_heavy | 6.82e-08 | 15 | 297 | 6 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.82e-08 | 15 | 297 | 6 | IPR004273 | |
| Domain | Ldl_recept_b | 1.75e-06 | 14 | 297 | 5 | PF00058 | |
| Domain | LDLRB | 1.75e-06 | 14 | 297 | 5 | PS51120 | |
| Domain | - | 2.38e-06 | 39 | 297 | 7 | 2.120.10.30 | |
| Domain | LY | 2.59e-06 | 15 | 297 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.59e-06 | 15 | 297 | 5 | IPR000033 | |
| Domain | Interferon | 5.20e-06 | 17 | 297 | 5 | PF00143 | |
| Domain | INTERFERON_A_B_D | 5.20e-06 | 17 | 297 | 5 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 5.20e-06 | 17 | 297 | 5 | IPR000471 | |
| Domain | IFabd | 5.20e-06 | 17 | 297 | 5 | SM00076 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.54e-06 | 46 | 297 | 7 | IPR011042 | |
| Domain | Keratin_2_head | 3.26e-05 | 24 | 297 | 5 | IPR032444 | |
| Domain | Keratin_2_head | 3.26e-05 | 24 | 297 | 5 | PF16208 | |
| Domain | LDLR_class-A_CS | 3.74e-05 | 40 | 297 | 6 | IPR023415 | |
| Domain | Keratin_II | 4.92e-05 | 26 | 297 | 5 | IPR003054 | |
| Domain | Ldl_recept_a | 7.43e-05 | 45 | 297 | 6 | PF00057 | |
| Domain | - | 8.43e-05 | 46 | 297 | 6 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.08e-04 | 48 | 297 | 6 | PS01209 | |
| Domain | LDLa | 1.21e-04 | 49 | 297 | 6 | SM00192 | |
| Domain | LDLRA_2 | 1.21e-04 | 49 | 297 | 6 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.21e-04 | 49 | 297 | 6 | IPR002172 | |
| Domain | SPEC | 1.39e-04 | 32 | 297 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.39e-04 | 32 | 297 | 5 | IPR018159 | |
| Domain | FN3 | EPHB2 AXL PTPRO IGSF9 MERTK USH2A LRIT2 KALRN CSF2RB ROBO2 EPHA7 | 1.90e-04 | 185 | 297 | 11 | SM00060 |
| Domain | DUF5050 | 2.52e-04 | 2 | 297 | 2 | IPR032485 | |
| Domain | LRP5/6 | 2.52e-04 | 2 | 297 | 2 | IPR017049 | |
| Domain | DUF5050 | 2.52e-04 | 2 | 297 | 2 | PF16472 | |
| Domain | fn3 | 2.74e-04 | 162 | 297 | 10 | PF00041 | |
| Domain | FN3 | EPHB2 AXL PTPRO IGSF9 MERTK USH2A LRIT2 KALRN CSF2RB ROBO2 EPHA7 | 3.56e-04 | 199 | 297 | 11 | PS50853 |
| Domain | Spectrin | 4.37e-04 | 23 | 297 | 4 | PF00435 | |
| Domain | PH_dom-like | RAPH1 TBC1D2B ARHGEF17 MTMR10 PLEKHM1 BMX SBF1 OSBPL9 PLCB1 PLCB2 PLCG2 PREX1 TNS3 ARAP2 KALRN ARAP3 MTMR9 | 5.02e-04 | 426 | 297 | 17 | IPR011993 |
| Domain | AAA+_ATPase | 5.03e-04 | 144 | 297 | 9 | IPR003593 | |
| Domain | AAA | 5.03e-04 | 144 | 297 | 9 | SM00382 | |
| Domain | Tyr_kinase_cat_dom | 5.07e-04 | 88 | 297 | 7 | IPR020635 | |
| Domain | TyrKc | 5.07e-04 | 88 | 297 | 7 | SM00219 | |
| Domain | FN3_dom | EPHB2 AXL PTPRO IGSF9 MERTK USH2A LRIT2 KALRN CSF2RB ROBO2 EPHA7 | 5.39e-04 | 209 | 297 | 11 | IPR003961 |
| Domain | PLC-beta_C | 7.48e-04 | 3 | 297 | 2 | PF08703 | |
| Domain | PLC-beta_C | 7.48e-04 | 3 | 297 | 2 | IPR014815 | |
| Domain | PROTEIN_KINASE_TYR | 9.08e-04 | 97 | 297 | 7 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.08e-04 | 97 | 297 | 7 | IPR008266 | |
| Domain | Pkinase_Tyr | 1.08e-03 | 129 | 297 | 8 | PF07714 | |
| Domain | Spectrin_repeat | 1.09e-03 | 29 | 297 | 4 | IPR002017 | |
| Domain | Kinase-like_dom | EPHB2 RAPH1 TRPM7 AXL SRMS ACVR1 MAP3K12 PASK BMX CAMKV BUB1B MERTK KALRN CHD9 FRK MTOR MACF1 MAP2K7 EPHA7 | 1.14e-03 | 542 | 297 | 19 | IPR011009 |
| Domain | - | 1.16e-03 | 50 | 297 | 5 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.27e-03 | 51 | 297 | 5 | IPR012351 | |
| Domain | PPASE_MYOTUBULARIN | 1.27e-03 | 14 | 297 | 3 | PS51339 | |
| Domain | Myotubularin-like_Pase_dom | 1.27e-03 | 14 | 297 | 3 | IPR010569 | |
| Domain | Myotubularin_fam | 1.27e-03 | 14 | 297 | 3 | IPR030564 | |
| Domain | Myotub-related | 1.27e-03 | 14 | 297 | 3 | PF06602 | |
| Domain | KASH | 1.48e-03 | 4 | 297 | 2 | PS51049 | |
| Domain | KASH | 1.48e-03 | 4 | 297 | 2 | PF10541 | |
| Domain | KASH | 1.48e-03 | 4 | 297 | 2 | IPR012315 | |
| Domain | PLC-beta | 1.48e-03 | 4 | 297 | 2 | IPR016280 | |
| Domain | KASH | 1.48e-03 | 4 | 297 | 2 | SM01249 | |
| Domain | - | RAPH1 TBC1D2B ARHGEF17 MTMR10 PLEKHM1 BMX SBF1 OSBPL9 PLCG2 PREX1 TNS3 ARAP2 KALRN ARAP3 MTMR9 | 1.57e-03 | 391 | 297 | 15 | 2.30.29.30 |
| Domain | PLCYc | 1.57e-03 | 15 | 297 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.57e-03 | 15 | 297 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.57e-03 | 15 | 297 | 3 | PS50008 | |
| Domain | EF-hand_like | 1.57e-03 | 15 | 297 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 1.57e-03 | 15 | 297 | 3 | PF00387 | |
| Domain | PI-PLC_fam | 1.57e-03 | 15 | 297 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.57e-03 | 15 | 297 | 3 | IPR015359 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.66e-03 | 138 | 297 | 8 | IPR001245 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 ABHD17B USP17L6P USP17L22 USP17L15 USP17L8 | 2.05e-24 | 45 | 232 | 20 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.96e-12 | 191 | 232 | 21 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8 | 6.59e-10 | 221 | 232 | 20 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.23e-09 | 262 | 232 | 21 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 ITGA2B USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 KALRN USP17L11 USP17L5 USP17L10 CSF2RB ABHD17B USP17L6P USP17L22 USP17L15 USP17L8 | 2.73e-09 | 318 | 232 | 23 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8 | 1.13e-07 | 299 | 232 | 20 | M27574 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 6.09e-06 | 17 | 232 | 5 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 8.32e-06 | 18 | 232 | 5 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.11e-05 | 19 | 232 | 5 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.47e-05 | 20 | 232 | 5 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.90e-05 | 21 | 232 | 5 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 2.42e-05 | 22 | 232 | 5 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 2.42e-05 | 22 | 232 | 5 | M47616 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.05e-05 | 23 | 232 | 5 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 3.05e-05 | 23 | 232 | 5 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 3.81e-05 | 24 | 232 | 5 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 3.81e-05 | 24 | 232 | 5 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.81e-05 | 24 | 232 | 5 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 5.73e-05 | 26 | 232 | 5 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.18e-04 | 30 | 232 | 5 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.39e-04 | 31 | 232 | 5 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.39e-04 | 31 | 232 | 5 | M47964 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 1.44e-04 | 49 | 232 | 6 | M40046 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.18e-04 | 34 | 232 | 5 | MM15631 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 2.28e-04 | 19 | 232 | 4 | MM1571 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 2.51e-04 | 35 | 232 | 5 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 2.51e-04 | 35 | 232 | 5 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 3.28e-04 | 37 | 232 | 5 | M39785 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.07e-38 | 21 | 304 | 19 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.07e-38 | 21 | 304 | 19 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.07e-38 | 21 | 304 | 19 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.07e-38 | 21 | 304 | 19 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.07e-38 | 21 | 304 | 19 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.07e-38 | 21 | 304 | 19 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.60e-37 | 22 | 304 | 19 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.79e-35 | 24 | 304 | 19 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.42e-35 | 25 | 304 | 19 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.73e-34 | 26 | 304 | 19 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.86e-33 | 33 | 304 | 20 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 15780755 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 9806828 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.49e-33 | 34 | 304 | 20 | 21448158 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.13e-33 | 29 | 304 | 19 | 32527007 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.04e-32 | 35 | 304 | 20 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.04e-32 | 35 | 304 | 20 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.32e-32 | 36 | 304 | 20 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.01e-32 | 37 | 304 | 20 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.05e-26 | 50 | 304 | 19 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 1.38e-15 | 10 | 304 | 8 | 24207026 |
| Pubmed | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 1.49e-14 | 12 | 304 | 8 | 24695638 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L1 USP17L3 DNMT1 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 2.26e-14 | 19 | 304 | 9 | 28067227 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 8.92e-14 | 14 | 304 | 8 | 11793228 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 EPHX1 USP34 B4GALNT1 MAN2A1 AXL EXT1 PLXND1 LRP1B NXPE3 SORT1 LRIG2 TM9SF2 CANT1 TMEM245 OSBPL9 LPGAT1 TMEM131L C4A HECTD1 DNMT1 COL4A6 FKBP10 P4HA2 LRP12 TMEM248 ERO1B NEDD4L TMEM43 PDIA4 EDEM3 RRAGA LRP1 IPO13 LRP6 LRP5 EPDR1 | 3.71e-11 | 1201 | 304 | 37 | 35696571 |
| Pubmed | MYH7 RAPH1 STARD10 SANBR SRP9 IFIT5 LAMP5 NEB PTGFR NDUFS1 MEN1 GSPT2 CLCN4 KRT6C SYNE2 SIPA1L2 DNAH8 PREX1 NIPBL KRT6A KRT6B KRT7 RARRES1 SYNE1 PCLO GRIA2 APOB TMEM43 SKI PRPF8 OGDH CAPN11 PDIA4 IFT88 SBNO1 SUGCT SUPT16H TENM1 MACF1 NSMCE4A | 1.29e-10 | 1442 | 304 | 40 | 35575683 | |
| Pubmed | USP17L7 USP34 USP17L1 USP20 USP17L3 USP17L4 USP17L2 ABHD17B USP17L6P USP17L15 USP17L8 | 1.34e-10 | 81 | 304 | 11 | 12838346 | |
| Pubmed | 1.20e-09 | 14 | 304 | 6 | 9373155 | ||
| Pubmed | KIF21B USP34 SPAST TBC1D2B SANBR PLXND1 ADGRV1 HEPH PASK ST6GAL2 ATP11B SBF1 PLCB1 TMEM131L IGSF9 AKAP6 PITPNM2 IPO13 ROBO2 FAIM2 HERC4 | 1.13e-08 | 529 | 304 | 21 | 14621295 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | PLXND1 DNAH5 HECTD1 DOCK1 DYNC2H1 IFT88 LRP1 LRP2 TRAPPC10 DNAH11 | 1.94e-08 | 100 | 304 | 10 | 25807483 |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 2.06e-08 | 21 | 304 | 6 | 21337463 | |
| Pubmed | 2.19e-08 | 11 | 304 | 5 | 24639464 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | SBF1 ASCC3 HECTD1 DNMT1 DOCK1 FLII KRT7 PRPF8 NBAS ARAP3 MTOR SUPT16H SMARCA2 | 3.11e-08 | 202 | 304 | 13 | 33005030 |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 3.72e-08 | 12 | 304 | 5 | 16611902 | |
| Pubmed | 3.72e-08 | 12 | 304 | 5 | 8245849 | ||
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 3.72e-08 | 12 | 304 | 5 | 7530016 | |
| Pubmed | 3.72e-08 | 12 | 304 | 5 | 9794206 | ||
| Pubmed | 3.72e-08 | 12 | 304 | 5 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 3.72e-08 | 12 | 304 | 5 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 3.72e-08 | 12 | 304 | 5 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 3.72e-08 | 12 | 304 | 5 | 7684767 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 3.72e-08 | 12 | 304 | 5 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 3.72e-08 | 12 | 304 | 5 | 3758677 | |
| Pubmed | 3.72e-08 | 12 | 304 | 5 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 3.72e-08 | 12 | 304 | 5 | 8760352 | |
| Pubmed | 3.72e-08 | 12 | 304 | 5 | 17451966 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 3.72e-08 | 12 | 304 | 5 | 8672140 | |
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 6.00e-08 | 13 | 304 | 5 | 12930842 | |
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 2471809 | ||
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 8438572 | ||
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 9343822 | ||
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 6.00e-08 | 13 | 304 | 5 | 2987810 | |
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 19130550 | ||
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 6.00e-08 | 13 | 304 | 5 | 2014240 | |
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 18005734 | ||
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 6.00e-08 | 13 | 304 | 5 | 6094686 | |
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 1655578 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 6.00e-08 | 13 | 304 | 5 | 23255800 | |
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 7523540 | ||
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 22739040 | ||
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 6.00e-08 | 13 | 304 | 5 | 18726328 | |
| Pubmed | 6.00e-08 | 13 | 304 | 5 | 18572754 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 9.27e-08 | 14 | 304 | 5 | 7526537 | |
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 19559726 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 9.27e-08 | 14 | 304 | 5 | 7532202 | |
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 9.27e-08 | 14 | 304 | 5 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 9.27e-08 | 14 | 304 | 5 | 17517919 | |
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 25972534 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 7583919 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 2987811 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 9.27e-08 | 14 | 304 | 5 | 15254193 | |
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 8345204 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 15240719 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 16418394 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 18272764 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 11884139 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 19004943 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 14983024 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 21172865 | ||
| Pubmed | 9.27e-08 | 14 | 304 | 5 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 9.27e-08 | 14 | 304 | 5 | 1381203 | |
| Pubmed | 1.38e-07 | 15 | 304 | 5 | 8786318 | ||
| Pubmed | 1.38e-07 | 15 | 304 | 5 | 15684736 | ||
| Pubmed | 1.38e-07 | 15 | 304 | 5 | 9520456 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 1.38e-07 | 15 | 304 | 5 | 8661419 | |
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 1.38e-07 | 15 | 304 | 5 | 17180012 | |
| Interaction | BRICD5 interactions | B4GALNT1 MAN2A1 NXPE3 SORT1 LRIG2 TM9SF2 CANT1 TMEM131L LRP12 TMEM248 ERO1B CPE CNNM1 EPHA7 | 1.05e-06 | 194 | 294 | 14 | int:BRICD5 |
| Interaction | CIB2 interactions | 2.76e-06 | 81 | 294 | 9 | int:CIB2 | |
| Interaction | ISG15 interactions | EPHX1 EPPK1 SPAST IFIT5 EFTUD2 SENP1 TM9SF2 TAF2 ASCC3 HSPA4 DYNC1H1 FLII IARS1 TMEM43 PRPF8 OGDH IFNA2 IFNA5 IFNA14 SUPT16H DEPDC7 HERC4 | 3.90e-06 | 494 | 294 | 22 | int:ISG15 |
| Interaction | LRRC31 interactions | SBF1 ASCC3 HECTD1 DNMT1 DOCK1 FLII KRT7 PRPF8 NBAS ARAP3 MTOR SUPT16H SMARCA2 | 1.05e-05 | 205 | 294 | 13 | int:LRRC31 |
| Interaction | IFNA5 interactions | 1.37e-05 | 22 | 294 | 5 | int:IFNA5 | |
| Interaction | ERP44 interactions | PFAS ITGA2B EFTUD2 PTPRO ZNF282 ERO1B PRPF8 PDIA4 EDEM3 B3GNT2 TRAPPC10 EPHA7 | 2.94e-05 | 194 | 294 | 12 | int:ERP44 |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.95e-16 | 79 | 304 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.59e-10 | 222 | 304 | 14 | chr4p16 |
| Cytoband | 9p22 | 5.87e-07 | 25 | 304 | 5 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | B4GALNT1 MAP3K12 SENP1 KRT6C SPRYD4 KRT6A KRT6B KRT7 KRT82 LRP1 FAIM2 | 1.38e-04 | 423 | 304 | 11 | chr12q13 |
| Cytoband | 2q33.2 | 2.18e-04 | 18 | 304 | 3 | 2q33.2 | |
| Cytoband | 8p23.1 | 5.94e-04 | 154 | 304 | 6 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.01e-03 | 234 | 304 | 7 | chr8p23 | |
| Cytoband | 12q13.13 | 1.04e-03 | 67 | 304 | 4 | 12q13.13 | |
| GeneFamily | Low density lipoprotein receptors | 1.88e-09 | 13 | 188 | 6 | 634 | |
| GeneFamily | Fibronectin type III domain containing | 6.87e-06 | 160 | 188 | 10 | 555 | |
| GeneFamily | Keratins, type II | 7.73e-06 | 27 | 188 | 5 | 609 | |
| GeneFamily | Interferons | 1.85e-05 | 32 | 188 | 5 | 598 | |
| GeneFamily | Dyneins, axonemal | 2.42e-05 | 17 | 188 | 4 | 536 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 4.59e-04 | 15 | 188 | 3 | 903 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 6.37e-04 | 4 | 188 | 2 | 1244 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 6.37e-04 | 4 | 188 | 2 | 1252 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 9.48e-04 | 19 | 188 | 3 | 832 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.44e-03 | 206 | 188 | 8 | 682 | |
| GeneFamily | Arachidonate lipoxygenases | 1.57e-03 | 6 | 188 | 2 | 407 | |
| GeneFamily | Sterile alpha motif domain containing | 2.25e-03 | 88 | 188 | 5 | 760 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.89e-03 | 8 | 188 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.69e-03 | 9 | 188 | 2 | 1234 | |
| GeneFamily | SH2 domain containing | 4.08e-03 | 101 | 188 | 5 | 741 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.28e-19 | 86 | 302 | 19 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.48e-17 | 112 | 302 | 19 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 LPGAT1 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.06e-15 | 160 | 302 | 20 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 EPHX1 USP17L21 USP17L1 USP17L20 STARD10 NAPA USP17L19 ITGA2B USP20 USP17L18 USP17L17 USP17L3 LPGAT1 SPRYD4 ARAP2 USP17L13 PITPNM2 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P DEPDC7 USP17L22 USP17L15 USP17L8 | 5.52e-10 | 647 | 302 | 29 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 EPHX1 USP17L21 USP17L1 USP17L20 STARD10 SRMS NAPA USP17L19 ITGA2B USP20 USP17L18 USP17L17 USP17L3 LPGAT1 C4A C4B SPRYD4 ARAP2 USP17L13 PITPNM2 USP17L4 USP17L2 ERO1B USP17L12 USP17L11 USP17L5 FAM117B USP17L10 RRP9 USP17L6P MTFR2 DEPDC7 USP17L22 USP17L15 USP17L8 | 2.81e-07 | 1226 | 302 | 36 | MM979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 SENP1 USP17L17 OSBPL9 USP17L3 USP17L13 USP17L4 THEMIS USP17L2 USP17L12 USP17L11 COBLL1 USP17L5 USP17L10 CCNG2 HOOK3 ARL10 SUGCT IRAG2 USP17L6P RBM6 TCEANC2 CD72 USP17L22 HERC4 USP17L15 USP17L8 | 9.56e-07 | 1072 | 302 | 32 | MM1031 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | EPHB2 TBC1D2B PEX1 PFAS ARHGEF17 MEN1 SBF1 C4B PLCG2 COL4A6 OGDH PDIA4 IPO13 LRP5 | 4.42e-06 | 276 | 302 | 14 | M3063 |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 6.32e-06 | 85 | 302 | 8 | MM684 | |
| Coexpression | GABRIELY_MIR21_TARGETS | USP34 RAPH1 TRPM7 PTGFR ATP11B SYNE2 LPGAT1 HECTD1 NIPBL TRIM2 COBLL1 MEGF9 KLHL15 ANO3 | 7.49e-06 | 289 | 302 | 14 | M2196 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | USP34 LRIG2 CAMKV KCND1 BANP PPFIBP2 VPS13D LLGL2 KLHL36 TRAPPC10 FAIM2 | 2.14e-05 | 199 | 302 | 11 | M4526 |
| Coexpression | GSE7852_TREG_VS_TCONV_FAT_DN | RELN EPSTI1 INPP1 STARD10 TBC1D2B ATP11B TMEM131L LRP12 THEMIS RBM6 WDR12 | 2.24e-05 | 200 | 302 | 11 | M5735 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.83e-05 | 169 | 302 | 10 | M39230 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 KIF21B RELN SPAST RAPH1 APC2 TBC1D2B PEX1 NEB LRP1B FSIP2 ST6GAL2 CLCN4 PTPRO AKAP6 LRP12 TRIM2 NEDD4L PCLO SYT6 GRIA2 FAM117B NLGN1 CELF1 MEGF9 TENM1 ROBO2 PCDH1 GABRA1 | 3.58e-05 | 1106 | 302 | 29 | M39071 |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 9.06e-05 | 194 | 302 | 10 | M8864 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | TBC1D2B SORT1 EFHC1 PLCB1 TNS3 DET1 FAM117B CCNG2 SMARCA2 ANO3 | 1.03e-04 | 197 | 302 | 10 | M9862 |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | EPHB2 B4GALNT1 INPP1 PCBD2 FKBP10 CRP CLEC4D TENM1 LRP6 LRP5 | 1.12e-04 | 199 | 302 | 10 | M3641 |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP | B4GALNT1 SPAST SRMS PCBD2 TM9SF2 SIPA1L2 PRPF8 CRP CELF1 CLEC4D | 1.12e-04 | 199 | 302 | 10 | M3639 |
| Coexpression | GSE3982_EOSINOPHIL_VS_DC_UP | KIF21B MYH7 IFIT5 CHRNB2 SYNE2 TMEM131L DNAH3 SLC6A16 SYNE1 SERPINA2 | 1.12e-04 | 199 | 302 | 10 | M5399 |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 1.16e-04 | 200 | 302 | 10 | M3390 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP | 1.16e-04 | 200 | 302 | 10 | M3612 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP | KIF21B GSPT2 CLCN4 NIPBL ARAP2 SLC6A16 SBNO1 SUPT16H SMARCA2 CD72 | 1.16e-04 | 200 | 302 | 10 | M4442 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ADGRV1 NEB LRP1B USH2A DNAH5 KALRN MROH2A PCLO APOB TENM1 LRP2 ANO3 EPHA7 DNAH11 | 2.03e-12 | 184 | 297 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ADGRV1 NEB LRP1B USH2A DNAH5 KALRN MROH2A PCLO APOB TENM1 LRP2 ANO3 EPHA7 DNAH11 | 2.03e-12 | 184 | 297 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ADGRV1 NEB LRP1B USH2A DNAH5 KALRN MROH2A PCLO APOB TENM1 LRP2 ANO3 EPHA7 DNAH11 | 2.03e-12 | 184 | 297 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 TRABD2B CYP24A1 SYNE2 PLCB1 TNS3 FOXP2 SYNE1 CPE NLGN1 IFT88 TENM1 EPHA7 DNAH11 | 3.28e-11 | 186 | 297 | 14 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 TRABD2B CYP24A1 ADGRV1 PTGFR SYNE2 PLCB1 TNS3 FOXP2 NLGN1 IFT88 TENM1 EPHA7 | 4.78e-10 | 188 | 297 | 13 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | USP34 SPAST MAN2A1 ADGRV1 BIRC6 NDUFS1 CEP350 ATP11B HECTD1 DYNC1H1 FRK TRAPPC10 PUS7L | 6.60e-10 | 193 | 297 | 13 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | MYH7 LAMP5 SORT1 ALOX12B NEDD4L KALRN SYNE1 GRIA2 NLGN1 CRYM CELF1 SBNO1 | 2.47e-09 | 175 | 297 | 12 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | MYH7 LAMP5 SORT1 ALOX12B NEDD4L KALRN SYNE1 GRIA2 NLGN1 CRYM CELF1 SBNO1 | 2.47e-09 | 175 | 297 | 12 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 MTMR10 SYNE2 PLCB1 DNAH5 TNS3 DOCK1 FOXP2 COBLL1 CPE NLGN1 EPHA7 | 6.64e-09 | 191 | 297 | 12 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 LRP1B C4B USH2A DNAH5 KRT7 MROH2A PCLO NLGN1 LRP2 DNAH11 | 1.98e-08 | 169 | 297 | 11 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | USP34 TRPM7 BIRC6 SYNE2 PLCB1 TMEM131L NIPBL DYNC1H1 ARAP2 ERO1B MACF1 | 5.91e-08 | 188 | 297 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CEP350 TM9SF2 OSBPL9 PLCG2 TNS3 ARAP2 P2RY12 SYNE1 MROH2A FAM117B MACF1 | 7.33e-08 | 192 | 297 | 11 | 1ccc47792edf9ee23501c8e2165d11271636b66a |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTGFR SYNE2 PLCB1 DNAH5 PITPNM2 KRT7 TRIM2 FOXP2 SYNE1 COBLL1 LLGL2 | 7.72e-08 | 193 | 297 | 11 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTGFR SYNE2 PLCB1 DNAH5 PITPNM2 KRT7 TRIM2 FOXP2 SYNE1 COBLL1 LLGL2 | 7.72e-08 | 193 | 297 | 11 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SANBR CFAP100 EFHC1 PLCG2 DNAH5 AKAP6 DNAH3 DYNC2H1 SYNE1 IFT88 DNAH11 | 8.14e-08 | 194 | 297 | 11 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRPM7 CYP20A1 CEP350 ASCC3 AKAP6 CHD9 CPE SUPT16H PODN MACF1 | 3.12e-07 | 176 | 297 | 10 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | TRABD2B LRP1B HSPA4 COBLL1 PCLO NLGN1 LLGL2 SUGCT SLC17A1 LRP2 | 3.12e-07 | 176 | 297 | 10 | 36f77d878a53b30465b0dea8333a3865dba75613 |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | TRABD2B CYP24A1 SYNE2 PCLO NLGN1 SUGCT SLC17A1 TENM1 LRP2 EPHA7 | 3.84e-07 | 180 | 297 | 10 | 358923e4228035a3e90e2957392089219e90dcd7 |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | TRABD2B CYP24A1 SYNE2 NLGN1 CNNM1 SUGCT SLC17A1 TENM1 LRP2 EPHA7 | 4.47e-07 | 183 | 297 | 10 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | CYP24A1 SYNE2 FOXP2 CPE NLGN1 CNNM1 SUGCT SLC17A1 LRP2 EPHA7 | 4.70e-07 | 184 | 297 | 10 | 51ed1ebfdef45149541917c66cbacad87072e51f |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 ADGRV1 LRP1B SYNE2 PLCB1 DNAH5 PITPNM2 TRIM2 FOXP2 FRK | 6.01e-07 | 189 | 297 | 10 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 ADGRV1 LRP1B SYNE2 PLCB1 DNAH5 PITPNM2 TRIM2 FOXP2 FRK | 6.01e-07 | 189 | 297 | 10 | 5d902a4660a27548764bf04c6de152b565da835c |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | TRABD2B TBC1D5 EXT1 SYNE2 NLGN1 SUGCT SLC17A1 RBM6 LRP2 MACF1 | 6.94e-07 | 192 | 297 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | EPHX1 ADGRV1 CFAP100 EFHC1 DNAH5 ALOX15 AKAP6 DNAH3 DYNC2H1 DNAH11 | 7.28e-07 | 193 | 297 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | CATSPERD CFAP100 EFHC1 DNAH5 AKAP6 DNAH3 DYNC2H1 SYNE1 IFT88 DNAH11 | 7.28e-07 | 193 | 297 | 10 | ad58f5080e0ba65c845056ea6b79037b636e9c64 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.63e-07 | 194 | 297 | 10 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ASCC3 DYNC1H1 ERO1B DYNC2H1 PCLO CPE SPHKAP MACF1 ROBO2 | 8.00e-07 | 195 | 297 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ASCC3 DYNC1H1 ERO1B DYNC2H1 PCLO CPE SPHKAP MACF1 ROBO2 | 8.00e-07 | 195 | 297 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.38e-07 | 196 | 297 | 10 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 SPTLC3 TRABD2B CYP24A1 SYNE2 TNS3 FOXP2 COBLL1 NLGN1 LLGL2 | 8.77e-07 | 197 | 297 | 10 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SANBR CFAP100 SYNE2 DNAH5 AKAP6 DNAH3 DPY19L2 DYNC2H1 SYNE1 DNAH11 | 8.77e-07 | 197 | 297 | 10 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | LRP1B ST6GAL2 AKAP6 PITPNM2 COL4A6 SYNE1 GRIA2 NLGN1 EPHA7 DNAH11 | 9.19e-07 | 198 | 297 | 10 | 22e766df1276c5b14aa0d83f434f47140ebb98ea |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CNTLN GSPT2 FKBP10 RARRES1 FOXP2 SPHKAP LRP1 PODN ROBO2 EPHA7 | 9.62e-07 | 199 | 297 | 10 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | USP34 EPSTI1 BIRC6 CEP350 SYNE2 PLCG2 NIPBL DYNC1H1 ARAP2 MACF1 | 1.01e-06 | 200 | 297 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 160 | 297 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 160 | 297 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.47e-06 | 162 | 297 | 9 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.47e-06 | 162 | 297 | 9 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.47e-06 | 162 | 297 | 9 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 164 | 297 | 9 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | Tuft-tuft-1|World / Class top | 1.99e-06 | 168 | 297 | 9 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 170 | 297 | 9 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-06 | 175 | 297 | 9 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 176 | 297 | 9 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 177 | 297 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 MAN2A1 PLCG2 HMBOX1 KRT7 DPY19L2 NEDD4L FAM117B DNAH11 | 3.51e-06 | 180 | 297 | 9 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-06 | 181 | 297 | 9 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.68e-06 | 181 | 297 | 9 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-06 | 181 | 297 | 9 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 182 | 297 | 9 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-06 | 182 | 297 | 9 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 182 | 297 | 9 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-06 | 182 | 297 | 9 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-06 | 182 | 297 | 9 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-06 | 183 | 297 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 183 | 297 | 9 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 183 | 297 | 9 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.59e-06 | 186 | 297 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-06 | 187 | 297 | 9 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 4.79e-06 | 187 | 297 | 9 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.01e-06 | 188 | 297 | 9 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 189 | 297 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 189 | 297 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.23e-06 | 189 | 297 | 9 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-06 | 190 | 297 | 9 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.46e-06 | 190 | 297 | 9 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 190 | 297 | 9 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 5.46e-06 | 190 | 297 | 9 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.69e-06 | 191 | 297 | 9 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | SPTLC3 TRABD2B NEXMIF CYP24A1 LRP1B SYNE2 PLCB1 TRIM2 COBLL1 | 5.69e-06 | 191 | 297 | 9 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 5.94e-06 | 192 | 297 | 9 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-06 | 145 | 297 | 8 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 193 | 297 | 9 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 193 | 297 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.19e-06 | 193 | 297 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-06 | 194 | 297 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 6.61e-06 | 147 | 297 | 8 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.73e-06 | 195 | 297 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.73e-06 | 195 | 297 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-06 | 195 | 297 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 7.01e-06 | 196 | 297 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 7.31e-06 | 197 | 297 | 9 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.67e-06 | 150 | 297 | 8 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.93e-06 | 199 | 297 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.93e-06 | 199 | 297 | 9 | 3b2bd3caf4d189a1726a737b0121860b265eec04 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 8.25e-06 | 200 | 297 | 9 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 8.25e-06 | 200 | 297 | 9 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.02e-05 | 156 | 297 | 8 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 158 | 297 | 8 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 161 | 297 | 8 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.35e-05 | 162 | 297 | 8 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 170 | 297 | 8 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 170 | 297 | 8 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 170 | 297 | 8 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 171 | 297 | 8 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 173 | 297 | 8 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-05 | 173 | 297 | 8 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 173 | 297 | 8 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 173 | 297 | 8 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 176 | 297 | 8 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| Drug | AC1L1G9E | 1.16e-06 | 28 | 288 | 6 | CID000003586 | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | EXT1 ARHGEF17 CHRNB2 CEP350 CLCN4 HPX KRT6B PRPH2 SKI CRY2 PDIA4 CCNG2 EDEM3 | 1.47e-06 | 197 | 288 | 13 | 4138_UP |
| Drug | CHEMBL466993 | 2.67e-06 | 32 | 288 | 6 | CID005320808 | |
| Drug | Ethylnitrosourea | EPHX1 RELN ADGRV1 RS1 TYR PLCG2 HECTD1 DYNC1H1 DNMT1 DYNC2H1 PPP1R3C TH IFT88 MTOR LRP5 | 5.02e-06 | 291 | 288 | 15 | ctd:D005038 |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | EPHB2 DOCK4 APC2 CHM HPX ALOX15 KRT6B NEDD4L VPS13D ABHD17B KDM8 PCDH1 | 8.48e-06 | 197 | 288 | 12 | 3351_UP |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | TBC1D2B CLCN4 MERTK COL4A6 ERO1B NLGN1 CRY2 EDEM3 MEGF9 LRP1 KDM8 PCDH1 | 8.92e-06 | 198 | 288 | 12 | 3793_DN |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A | SPAST PEX1 SYNE2 MMP14 DOCK1 TRIM2 PPP1R3C VPS13D RIC8B KLHL36 LRP6 HERC4 | 9.39e-06 | 199 | 288 | 12 | 5836_DN |
| Drug | plakin | 9.43e-06 | 82 | 288 | 8 | CID000018752 | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | USP34 SPTLC3 EXT1 ARHGEF17 ATP11B MERTK PPFIBP2 COBLL1 SKI TIGD6 KDM8 HERC4 | 9.88e-06 | 200 | 288 | 12 | 4701_DN |
| Drug | Biliton | 1.21e-05 | 41 | 288 | 6 | CID000002974 | |
| Drug | 2,3,4-trihydroxybenzoate | 1.97e-05 | 5 | 288 | 3 | CID000011874 | |
| Drug | ibuprofen | TRPM7 TYR SAA4 HPX HSPA4 ALOX12B ALOX15 APOB APOC2 IFNA2 IFNA5 IFNA6 CRP PDIA4 | 2.51e-05 | 294 | 288 | 14 | CID000003672 |
| Drug | monatepil | 2.90e-05 | 29 | 288 | 5 | CID000060810 | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | B4GALNT1 GMIP MAP3K12 PASK MMP14 FLII KRT6B OGDH KDM4D LRP2 LRP5 | 3.55e-05 | 192 | 288 | 11 | 4330_DN |
| Drug | SKF83742 | 3.89e-05 | 6 | 288 | 3 | CID000130828 | |
| Drug | SC-791 | 3.89e-05 | 6 | 288 | 3 | CID010291510 | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | EPHB2 TBC1D5 LRIG2 PASK CLCN4 MMP14 ERO1B NEDD4L VPS13D B3GNT2 SMARCA2 | 3.90e-05 | 194 | 288 | 11 | 4572_DN |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | IFIT5 SYNE2 PLCB1 MERTK ALOX15 LRP12 TRIM2 PPFIBP2 PCLO CCNG2 HERC4 | 4.09e-05 | 195 | 288 | 11 | 4393_DN |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | EPHB2 EPPK1 AXL NAPA PLXND1 SYNE2 DOCK1 SYNE1 EDEM3 ABHD17B MEGF9 | 4.09e-05 | 195 | 288 | 11 | 7362_DN |
| Drug | probucol | 4.28e-05 | 162 | 288 | 10 | CID000004912 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | USP34 PEX1 NEB ARHGEF17 SORT1 PLCB1 DNAH3 TRIM2 SKI CCNG2 MACF1 | 4.28e-05 | 196 | 288 | 11 | 5425_DN |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | CEP350 PASK KRT7 NEDD4L DYNC2H1 CPE OGDH KLHL36 TRAPPC10 MACF1 HERC4 | 4.49e-05 | 197 | 288 | 11 | 5340_DN |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A | TBC1D2B PEX1 IFIT5 NEB PASK SBF1 CRY2 LRP2 TRAPPC10 LRP6 PUS7L | 4.49e-05 | 197 | 288 | 11 | 2304_DN |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 197 | 288 | 11 | 4974_DN | |
| Drug | 4,4'-thiodiphenol | 4.76e-05 | 32 | 288 | 5 | CID000017570 | |
| Drug | bropirimine | 4.86e-05 | 52 | 288 | 6 | CID000065457 | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | EPHB2 PLXND1 PASK HPS1 DOCK1 COBLL1 CPE OGDH VPS13D LRP6 LRP5 | 5.15e-05 | 200 | 288 | 11 | 7002_DN |
| Drug | AC1L1F9Q | PEX1 ADGRV1 KRT6C USH2A ALOX12B ALOX15 KRT6A KRT6B PPFIBP2 APOB CRP | 5.38e-05 | 201 | 288 | 11 | CID000003144 |
| Drug | ethylnylestradiol | TRPM7 AXL CYP24A1 CYP20A1 ACVR1 LRP1B F7 SORT1 KRT6C HPX OSBPL9 TAF2 MERTK MMP14 HSPA4 KRT6A KRT6B LRP12 KRT7 KRT82 APOB APOC2 SKI IFNA2 IFNA5 IFNA6 CRP CCNG2 SLC17A1 LRP1 LRP2 LRP6 LRP5 | 5.49e-05 | 1251 | 288 | 33 | CID000003285 |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 PLCB2 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 CHD9 USP17L10 USP17L6P LRP2 USP17L22 USP17L15 USP17L8 | 3.33e-29 | 69 | 295 | 23 | DOID:1682 (implicated_via_orthology) |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.31e-28 | 46 | 295 | 20 | DOID:5426 (implicated_via_orthology) |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.35e-07 | 7 | 295 | 4 | C0751337 | |
| Disease | Unipolar Depression | RELN RAPH1 GMIP PLCB1 FOXP2 KALRN PCLO GRIA2 IFNA2 CRP TH CSF2RB MTOR LRP1 | 4.03e-07 | 259 | 295 | 14 | C0041696 |
| Disease | Major Depressive Disorder | RELN RAPH1 GMIP PLCB1 FOXP2 KALRN PCLO GRIA2 CRP TH CSF2RB MTOR LRP1 | 1.18e-06 | 243 | 295 | 13 | C1269683 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.93e-06 | 4 | 295 | 3 | cv:CN293514 | |
| Disease | Malignant neoplasm of breast | SPAST RAPH1 CYP24A1 APC2 ACVR1 PKDREJ KCNH1 SYNE2 PLCB1 MMP14 NIPBL DNMT1 AKAP6 KALRN WDR88 DYNC2H1 SYNE1 IFNA2 TRMT10A LLGL2 HOOK3 ARAP3 SBNO1 MTOR RRP9 TENM1 MACF1 MAP2K7 | 4.24e-06 | 1074 | 295 | 28 | C0006142 |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 9.75e-06 | 5 | 295 | 3 | C0410190 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 9.75e-06 | 5 | 295 | 3 | C1450051 | |
| Disease | household income | TRPM7 EXT1 LRP1B CAMKV PITPNM2 FOXP2 KALRN AXDND1 ARAP3 SBNO1 SMARCA2 RBM6 PCDH1 | 1.35e-05 | 304 | 295 | 13 | EFO_0009695 |
| Disease | Emery-Dreifuss muscular dystrophy | 1.93e-05 | 6 | 295 | 3 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.93e-05 | 6 | 295 | 3 | C0410189 | |
| Disease | reticulocyte count | USP34 ACVR1 BIRC6 SENP1 ATP11B SYNE2 PLCB1 TMEM131L C4B PLCG2 TAF2 HSPA4 TNS3 DNMT1 PITPNM2 TRIM2 COBLL1 FAM117B SKI PRPF8 SERPINA2 MRPL4 SPC24 CELF1 MEGF9 LRP5 | 2.11e-05 | 1045 | 295 | 26 | EFO_0007986 |
| Disease | reticulocyte measurement | USP34 PFAS ACVR1 BIRC6 SENP1 ATP11B SYNE2 PLCB1 TMEM131L PLCG2 HSPA4 PREX1 TNS3 DNMT1 PITPNM2 TRIM2 COBLL1 SKI PRPF8 SERPINA2 MRPL4 SPC24 CELF1 MEGF9 RBM6 LRP5 | 2.40e-05 | 1053 | 295 | 26 | EFO_0010700 |
| Disease | Colorectal Carcinoma | TRPM7 APC2 BUB1B DNAH8 AKAP6 COL4A6 DNAH3 KALRN POLD1 SYNE1 APOB CPE IFNA2 ARAP3 PANK4 TENM1 LRP1 LRP2 MUTYH EPHA7 | 3.07e-05 | 702 | 295 | 20 | C0009402 |
| Disease | Hemorrhage | 4.18e-05 | 20 | 295 | 4 | C0019080 | |
| Disease | Autistic Disorder | DOCK4 RELN INPP1 EXT1 CHRNB2 PASK C4B FOXP2 NLGN1 ROBO2 GABRA1 | 7.06e-05 | 261 | 295 | 11 | C0004352 |
| Disease | hypobetalipoproteinemia (is_marker_for) | 9.96e-05 | 2 | 295 | 2 | DOID:1390 (is_marker_for) | |
| Disease | retinoschisis (is_implicated_in) | 9.96e-05 | 2 | 295 | 2 | DOID:8465 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.04e-04 | 12 | 295 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | Schizophrenia | DOCK4 RELN NDUFS1 CHRNB2 TYR TMEM245 PLCB1 DNMT1 FOXP2 GRIA2 NLGN1 CRP CSF2RB SBNO1 MTOR B3GNT2 SMARCA2 LRP1 LRP2 MAP2K7 GABRA1 | 2.45e-04 | 883 | 295 | 21 | C0036341 |
| Disease | Endocrine System Diseases | 2.97e-04 | 3 | 295 | 2 | C0014130 | |
| Disease | Disorder of eye | 3.03e-04 | 212 | 295 | 9 | C0015397 | |
| Disease | pack-years measurement, systolic blood pressure | 3.58e-04 | 34 | 295 | 4 | EFO_0006335, EFO_0006526 | |
| Disease | Hypertriglyceridemia | 4.12e-04 | 15 | 295 | 3 | C0020557 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 4.88e-04 | 99 | 295 | 6 | EFO_0004611, EFO_0007878 | |
| Disease | sphingomyelin measurement | SPTLC3 SENP1 KRT6C SYNE2 USH2A DYNC1H1 ALOX15 KRT6A APOB FAIM2 | 5.28e-04 | 278 | 295 | 10 | EFO_0010118 |
| Disease | oculocutaneous albinism (is_implicated_in) | 5.90e-04 | 4 | 295 | 2 | DOID:0050632 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 5.90e-04 | 4 | 295 | 2 | DOID:898 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 5.90e-04 | 4 | 295 | 2 | C1706595 | |
| Disease | Juvenile Myoclonic Epilepsy of Janz | 5.90e-04 | 4 | 295 | 2 | C4551857 | |
| Disease | Pachyonychia congenita syndrome | 5.90e-04 | 4 | 295 | 2 | cv:C0265334 | |
| Disease | Impulsive Petit Mal Epilepsy | 5.90e-04 | 4 | 295 | 2 | C4553298 | |
| Disease | pachyonychia congenita (is_implicated_in) | 5.90e-04 | 4 | 295 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Myoclonic Epilepsy, Adolescent | 5.90e-04 | 4 | 295 | 2 | C4552768 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 5.90e-04 | 4 | 295 | 2 | C1721007 | |
| Disease | Kartagener syndrome (is_implicated_in) | 5.90e-04 | 4 | 295 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | Juvenile myoclonic epilepsy | 5.90e-04 | 4 | 295 | 2 | cv:C0270853 | |
| Disease | Myoclonic Epilepsy, Juvenile, 1 | 5.90e-04 | 4 | 295 | 2 | C4553087 | |
| Disease | X-12063 measurement | 5.97e-04 | 186 | 295 | 8 | EFO_0021283 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.02e-04 | 68 | 295 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 6.11e-04 | 39 | 295 | 4 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | Intellectual Disability | APC2 TAF2 ASCC3 DYNC1H1 AKAP6 SYNE1 GRIA2 TH MTOR KLHL15 SUPT16H LRP2 MACF1 | 6.23e-04 | 447 | 295 | 13 | C3714756 |
| Disease | Retinitis Pigmentosa | 6.34e-04 | 104 | 295 | 6 | C0035334 | |
| Disease | urate measurement | USP34 EXT1 ADGRV1 BIRC6 MEN1 SPRYD4 P4HA2 DNAH3 FOXP2 SKI FRK TIGD2 SLC17A1 RRP9 USP17L6P LRP1 RBM6 LRP2 FAIM2 HERC4 | 7.48e-04 | 895 | 295 | 20 | EFO_0004531 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.49e-04 | 148 | 295 | 7 | C0279702 | |
| Disease | Ciliopathies | 8.52e-04 | 110 | 295 | 6 | C4277690 | |
| Disease | myocardial infarction | PLCB2 PLCG2 CFAP161 MERTK KALRN DYNC2H1 APOB SKI SERPINA2 SPC24 WDR12 | 8.64e-04 | 350 | 295 | 11 | EFO_0000612 |
| Disease | Anxiety Disorders | 9.70e-04 | 44 | 295 | 4 | C0003469 | |
| Disease | Anxiety States, Neurotic | 9.70e-04 | 44 | 295 | 4 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 9.70e-04 | 44 | 295 | 4 | C1279420 | |
| Disease | interstitial cystitis (is_marker_for) | 9.77e-04 | 5 | 295 | 2 | DOID:13949 (is_marker_for) | |
| Disease | Pachyonychia Congenita | 9.77e-04 | 5 | 295 | 2 | C0265334 | |
| Disease | Bipolar Disorder | RELN INPP1 PLCB1 DNAH8 HSPA4 DNMT1 SYNE1 PCLO GRIA2 NLGN1 CRY2 TH GABRA1 | 1.13e-03 | 477 | 295 | 13 | C0005586 |
| Disease | uric acid measurement | USP34 TRPM7 CYP24A1 ACVR1 ADGRV1 BIRC6 DNAH3 DYNC2H1 COBLL1 SKI FRK SLC17A1 LRP2 FAIM2 HERC4 | 1.35e-03 | 610 | 295 | 15 | EFO_0004761 |
| Disease | age at diagnosis, substance-related disorder | 1.46e-03 | 6 | 295 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | adenosine measurement | 1.46e-03 | 6 | 295 | 2 | EFO_0010453 | |
| Disease | Idiopathic generalized epilepsy | 1.46e-03 | 6 | 295 | 2 | cv:C0270850 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.73e-03 | 171 | 295 | 7 | DOID:9352 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.86e-03 | 222 | 295 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | Renal Cell Carcinoma | 1.86e-03 | 128 | 295 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.86e-03 | 128 | 295 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.86e-03 | 128 | 295 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.86e-03 | 128 | 295 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.86e-03 | 128 | 295 | 6 | C1306837 | |
| Disease | recalcitrant atopic dermatitis | 2.02e-03 | 7 | 295 | 2 | EFO_1000651 | |
| Disease | lung carcinoma (is_implicated_in) | 2.02e-03 | 7 | 295 | 2 | DOID:3905 (is_implicated_in) | |
| Disease | chronic mucus hypersecretion | 2.02e-03 | 7 | 295 | 2 | EFO_0005673 | |
| Disease | frozen shoulder | 2.02e-03 | 7 | 295 | 2 | EFO_1000941 | |
| Disease | Albinism, Oculocutaneous | 2.02e-03 | 7 | 295 | 2 | C0078918 | |
| Disease | aspartate aminotransferase measurement | KIF21B TRPM7 AXL TBC1D5 STARD10 SRMS BIRC6 PLEKHM1 CLCN4 MERTK P4HA2 NEDD4L KALRN COBLL1 SERPINA2 CNNM1 FRK CELF1 MTOR | 2.03e-03 | 904 | 295 | 19 | EFO_0004736 |
| Disease | body mass index, osteoarthritis | 2.09e-03 | 54 | 295 | 4 | EFO_0004340, MONDO_0005178 | |
| Disease | glycerol measurement | 2.17e-03 | 26 | 295 | 3 | EFO_0010115 | |
| Disease | migraine disorder, pulse pressure measurement | 2.17e-03 | 26 | 295 | 3 | EFO_0005763, MONDO_0005277 | |
| Disease | attempted suicide | 2.17e-03 | 178 | 295 | 7 | EFO_0004321 | |
| Disease | triglycerides in medium VLDL measurement | 2.24e-03 | 55 | 295 | 4 | EFO_0022155 | |
| Disease | triglycerides in large VLDL measurement | 2.39e-03 | 56 | 295 | 4 | EFO_0022178 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 2.52e-03 | 136 | 295 | 6 | DOID:9352 (is_marker_for) | |
| Disease | cognitive function measurement | LVRN USP34 MAN2A1 TBC1D5 STARD10 EXT1 BIRC6 LRP1B PLEKHM1 ST6GAL2 TMEM245 PLCB1 TAF2 USH2A DNAH5 PREX1 AKAP6 NEDD4L KALRN PPP1R3C EDEM3 FRK ARAP3 RBM6 PCDH1 EPHA7 | 2.64e-03 | 1434 | 295 | 26 | EFO_0008354 |
| Disease | lifestyle measurement | 2.64e-03 | 235 | 295 | 8 | EFO_0010724 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 2.68e-03 | 8 | 295 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | helping behavior measurement | 2.68e-03 | 8 | 295 | 2 | EFO_0008538 | |
| Disease | Juvenile Myoclonic Epilepsy | 2.68e-03 | 8 | 295 | 2 | C0270853 | |
| Disease | osteoarthritis, spine, body mass index | 2.68e-03 | 8 | 295 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | Myocardial Infarction | 2.69e-03 | 95 | 295 | 5 | C0027051 | |
| Disease | Drug Withdrawal Symptoms | 2.72e-03 | 58 | 295 | 4 | C0086189 | |
| Disease | Withdrawal Symptoms | 2.72e-03 | 58 | 295 | 4 | C0087169 | |
| Disease | Substance Withdrawal Syndrome | 2.72e-03 | 58 | 295 | 4 | C0038587 | |
| Disease | phospholipids in VLDL measurement | 2.89e-03 | 59 | 295 | 4 | EFO_0022301 | |
| Disease | total lipids in VLDL measurement | 3.08e-03 | 60 | 295 | 4 | EFO_0022314 | |
| Disease | Epileptic encephalopathy | 3.29e-03 | 30 | 295 | 3 | C0543888 | |
| Disease | colorectal cancer (implicated_via_orthology) | 3.29e-03 | 30 | 295 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Pancreatic Neoplasm | 3.36e-03 | 100 | 295 | 5 | C0030297 | |
| Disease | Acute Confusional Migraine | 3.42e-03 | 9 | 295 | 2 | C0521664 | |
| Disease | Status Migrainosus | 3.42e-03 | 9 | 295 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 3.42e-03 | 9 | 295 | 2 | C0270858 | |
| Disease | Sick Headaches | 3.42e-03 | 9 | 295 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 3.42e-03 | 9 | 295 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 3.42e-03 | 9 | 295 | 2 | C0018984 | |
| Disease | cutaneous melanoma, hair color | 3.46e-03 | 62 | 295 | 4 | EFO_0000389, EFO_0003924 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFEEELTSKWLYLFE | 336 | Q9HAC7 | |
| KFGITESDWYRIKQS | 296 | Q8N9N5 | |
| ISWAEEYEARENFRK | 156 | O60566 | |
| EDDTWVTKLAYLTDI | 421 | P0CF97 | |
| ITVQEWSDRKSARSY | 146 | Q9UM22 | |
| ADETLQDTTLRYWER | 276 | Q5SZB4 | |
| FANKYSFWLTTVEER | 1646 | Q14031 | |
| FLTQVKESLSSYWES | 36 | P02655 | |
| LSDYEVAEKIWSNRA | 486 | Q8WWN8 | |
| DVKETFQYTLFRWAE | 61 | Q6P2P2 | |
| EEWIADIQQYSSDKR | 4771 | Q9NR09 | |
| SIIKFADQYIWSEDV | 326 | Q86XM0 | |
| SEWKTRYETQLELND | 56 | A6NNP5 | |
| EDSDAVWNELAYFKR | 606 | Q9NXG0 | |
| TLAASRYLDKTEQWS | 1021 | P0C0L5 | |
| LLYWSDEEAVVDFKA | 1041 | P26358 | |
| QVTTKYVLWVDDDFV | 346 | Q00973 | |
| TWSEKDLRELFEQYG | 26 | Q92879 | |
| VYASNEESRSQWLKA | 91 | P51813 | |
| WSNYVDLEQKLFDET | 216 | Q86XJ0 | |
| QSKEAFIDWARYDDS | 146 | Q86YB8 | |
| DEKSWFRETELYNTV | 241 | Q04771 | |
| AELDLEKSITWFSVY | 4741 | Q8WXG9 | |
| INDTEFFYWRELVSK | 236 | Q16589 | |
| TTLLDQFESRIYNEW | 676 | Q96DT5 | |
| TLSDYEVAEKIWFNE | 681 | Q8WZ64 | |
| TYEDFHTIDWLREKS | 26 | P51793 | |
| DWKLTDDTQRTRTYA | 306 | P21854 | |
| KSSKRSWLQEVYLTD | 171 | Q6P656 | |
| RGILKAYSDSQEDEW | 251 | Q96QD5 | |
| KTFSYSNAEQDDLWR | 531 | Q6Q4G3 | |
| DKEWDILLNTYTNTT | 836 | Q6Q4G3 | |
| ERSEFWSALLEKAYA | 206 | Q9UMQ6 | |
| LDLSLFSYDDKWVSV | 461 | Q7L5Y6 | |
| SLEISKDWQSETIEY | 741 | Q53SF7 | |
| YPRTESEWENSFALK | 626 | Q9BYT9 | |
| AVEDTVAAKLIYDSW | 296 | Q14894 | |
| YEAIRKAFRVWESAT | 141 | P50281 | |
| LSWLKEYQENSDIVS | 56 | P24386 | |
| ALKRTESAYDWTSLS | 516 | Q70E73 | |
| GWSELSERDAIYKEF | 51 | Q9H0N5 | |
| ESFKLARESWELLYS | 411 | Q9NVR2 | |
| SEVAQWRTKYETDAI | 1366 | P12883 | |
| NEYESRSLWKDVTFN | 661 | Q96SU4 | |
| VSDVIWNSLSRSYFK | 121 | O00255 | |
| ETLLAWVTSKFELYT | 476 | Q7L1V2 | |
| SRYSSTETLKDDDLW | 391 | Q96PE2 | |
| RFYWKEFVSEVDVLV | 136 | Q8N8L6 | |
| NETFWKLSSLEYLDL | 281 | Q7Z5L7 | |
| LVDIYIFSEDTTFKW | 301 | P49441 | |
| NLADYTWEEVFRVNK | 1256 | Q96RG2 | |
| SSAAWDETLLEKFYI | 96 | P01570 | |
| WENTAFSKTVQVYDR | 556 | Q8N4N3 | |
| FETWKNTLDRYPDTL | 51 | Q9NSA2 | |
| QRSRAEAESWYQTKY | 346 | P48668 | |
| KNWDDVLTVDYTRNA | 836 | Q13045 | |
| DWLTIETYKNIESYR | 106 | Q9Y561 | |
| SEERLYWTDIKTQTI | 1616 | Q9NZR2 | |
| TDDLTTWLYQRFVEK | 296 | Q92604 | |
| TWLYQRFVEKEDLLS | 301 | Q92604 | |
| ELFTTFSWDDQKVRR | 86 | Q9BWQ8 | |
| NSFTLKLEDTENWLY | 646 | P34932 | |
| SEFERFSLSTKWLVE | 916 | Q6P1M3 | |
| DSRRKFIWSEISYLS | 206 | Q16706 | |
| WIAIESLADRVYTSK | 766 | Q12866 | |
| SLADRVYTSKSDVWA | 771 | Q12866 | |
| QRSRAEAESWYQTKY | 346 | P02538 | |
| RAEAEAWYQTKFETL | 276 | P08729 | |
| QEFELYSSATSEWRL | 131 | Q96QG7 | |
| FETYSDWDREIKRTG | 221 | Q9NXD2 | |
| ADTSKEEWFTLYIAS | 386 | A6NDA9 | |
| LLAWTEKRASYELEF | 111 | Q9P107 | |
| RIDWDDDKFYSTSLK | 71 | A0A0C4DH43 | |
| ALDTRDDLFAYWEKL | 156 | Q8IYT1 | |
| LSQSALYWTDVVEDK | 1306 | Q07954 | |
| KEWFNYVTATRNEEL | 4756 | Q2LD37 | |
| KDREDSITYTTVDWR | 4906 | Q2LD37 | |
| TIFEEYARKALDFLW | 246 | Q9BZQ6 | |
| KLYWTDSETNRIEVA | 121 | O75197 | |
| QSSEVILDYSWEKLN | 66 | Q8N371 | |
| ARSWAYRDSLKAEEN | 231 | Q96J88 | |
| KIGWEYESTNISRDT | 1616 | Q5CZC0 | |
| ESRAQEENTWFSYLK | 116 | Q8WVQ1 | |
| SDLERVTSLKVYNWF | 316 | Q6NT76 | |
| EAIQYRKFTSASDVW | 796 | P29323 | |
| YLSWALDTNQEERDK | 251 | Q8IYD1 | |
| SKFIERWSTLEEKEY | 271 | P42262 | |
| AIAVFVYASDKEWIR | 86 | P43088 | |
| VYASDKEWIRFDQSN | 91 | P43088 | |
| TLEVTVWDYDRFSSN | 4786 | Q9Y6V0 | |
| DAITGKARYTLSEEW | 1531 | Q9Y4D7 | |
| QRSRAEAESWYQTKY | 346 | P04259 | |
| KRYETLEVDVASWFK | 381 | O14733 | |
| ERWDSYDLTIKVQDG | 241 | Q08174 | |
| DFQKYKTLWTEDRDV | 1006 | Q96JB1 | |
| NWVYKLSTSSDIIEE | 1476 | Q96JB1 | |
| SDRQLTLNEIYSWFT | 521 | O15409 | |
| YEDSRLIWFSDKTFE | 776 | Q5GLZ8 | |
| SSATWDETLLDKFYT | 96 | P01569 | |
| VSTSYIKVWDIRDSA | 1366 | O75037 | |
| WKENFDSAYTELNEI | 2676 | O60229 | |
| YIAQWFRDTTLETEK | 1676 | Q6KC79 | |
| EWKARETYDNISEIL | 56 | Q6B0I6 | |
| FDEDTKTIRNNSWLY | 406 | O95259 | |
| KSSFYAQDALRLWEI | 456 | P16050 | |
| YWSDVSEEAIKRTEF | 66 | O75581 | |
| GEKLYWTDSETNRIE | 106 | O75581 | |
| ALDFDVTDNRIYWTD | 666 | O75581 | |
| VTDNRIYWTDISLKT | 671 | O75581 | |
| WTIELKEDNISFSSY | 551 | Q9H1U4 | |
| WRLSKVQFVYDSSEK | 136 | Q9UJQ1 | |
| EYTIDVFFRQSWKDE | 86 | P14867 | |
| YDDIASRSKAEAEAW | 296 | Q9NSB4 | |
| AAESLAVDWVSRKLY | 3271 | P98164 | |
| SLDIFEDQLYWISKE | 4276 | P98164 | |
| LTYLFSRENSIWDEK | 291 | P16885 | |
| EEVAWTRYSQKDQLY | 611 | Q8N2Q7 | |
| TAENTLFYVKESTLW | 271 | Q9H244 | |
| SYWESTDVVSFLLRQ | 946 | Q9BZ72 | |
| EELLQWIKYSTTSDA | 621 | Q6NUT2 | |
| AYFDENWLNRIKTEV | 51 | Q86VS8 | |
| EAIQYRKFTSASDVW | 806 | Q15375 | |
| LIFLEYKASAQWSAE | 186 | A2RRP1 | |
| TAAYIKEWFEESLSQ | 81 | Q8ND30 | |
| KFQSTYEELTGWLRE | 5566 | Q9UPN3 | |
| LEYTKDARSDSWQLV | 3141 | P78509 | |
| NVSNLKVWDFYTEET | 1586 | O95248 | |
| TRVNISYWEGKDFRT | 151 | Q16827 | |
| VASYRVSKSSWLEED | 376 | O15460 | |
| VDLTDDALARKYWLT | 436 | Q9NVE7 | |
| STRFEEFLQRKWSSE | 261 | Q02218 | |
| VSLETRYWASVEEYI | 81 | Q9HBI5 | |
| ETLRWKLEDYFETDS | 481 | P42685 | |
| NEDWITFRTKTYLFE | 1146 | Q8NCM8 | |
| NVTDLAFDLYKSWLI | 56 | P20848 | |
| LTDFAEQYSIQDWAK | 2561 | P04114 | |
| LQWESYVKRFLDIAD | 1231 | O95996 | |
| TSSFDIQKAEWLRKY | 1591 | Q3L8U1 | |
| WDDDYVLKRQFSALV | 1761 | Q9ULT8 | |
| RVESFSEDEWNLLYV | 906 | Q8NFZ0 | |
| YFDVVLLDVWNKEDT | 141 | Q96AY3 | |
| FEVVYKRLQDSWEDA | 171 | P32927 | |
| LEKFSTWTNTEFRYL | 326 | P07099 | |
| IDTQFWEKAIQYFER | 631 | Q13099 | |
| SDKEEVRSLVTWGNY | 86 | Q13325 | |
| TERYDITNDKWEFVD | 396 | Q96M94 | |
| YWDDISQAAKDLVTR | 251 | Q8NCB2 | |
| ESKFISENYLVRWSS | 251 | Q14185 | |
| NEFKSLWVERTSLYL | 1431 | Q8N1I0 | |
| LWEAYFSSVEKIVLT | 411 | Q16394 | |
| EDLYSELNKWSFESI | 201 | Q07973 | |
| LFKEWGVTRLTFEYD | 106 | Q49AN0 | |
| QLWSTAYEFSIKSEE | 871 | Q8TD57 | |
| RDKATQTESAWAEEY | 246 | Q6P1L5 | |
| ERDIWSSATYELALK | 396 | Q5T1B0 | |
| TYWEDNKNSLISYLE | 356 | P16870 | |
| SERSLSAYAKRVNEW | 2181 | Q5VT06 | |
| SAYAKRVNEWDSRTE | 2186 | Q5VT06 | |
| SYATKRQDNEILIFW | 71 | P02741 | |
| DCWNEYFSKSLNRET | 96 | B2RV13 | |
| AFRDYTTWKLTLTKE | 126 | Q494V2 | |
| QETYFKSQAEWREEV | 376 | Q12852 | |
| DSLAVWNALEKYVTE | 501 | O75342 | |
| SAAWDETLLDKFYTE | 96 | P01563 | |
| SDQEVLEWYTAKDFI | 316 | Q5JVL4 | |
| RFISTYSWADAEEEK | 421 | Q12912 | |
| GFYRTSDQTWVKLER | 2691 | Q14204 | |
| SFGYWSKRQSDLRAE | 371 | Q6PII3 | |
| FIYQEVSRLWSKSAV | 21 | A6NNS2 | |
| ETKYELVTSSREEAW | 441 | Q6UW02 | |
| YWTDQEFEESLRLKF | 16 | Q92902 | |
| VTSESWRSFFKEALQ | 16 | P35542 | |
| ALWFSVSNDLKYDAE | 346 | A3KN83 | |
| YEKEEDLLQAWSTFI | 371 | P28340 | |
| FWSSDEKEQFRIYRV | 411 | O94829 | |
| DISEEDIKTVFYSWL | 456 | O43933 | |
| TLAASRYLDKTEQWS | 1021 | P0C0L4 | |
| ADRFTVSSDVTWFDK | 2831 | Q8TE73 | |
| SSVAWDERLLDKLYT | 96 | P05013 | |
| TAEYVEFEVKRALEW | 141 | P42345 | |
| SRVQSYFDGIKADWL | 126 | Q9H300 | |
| VRYLEEHTEFTWDQK | 626 | A6NES4 | |
| SSVVRFWYSLLKELE | 311 | Q5JXM2 | |
| SAVDAAFSWEEKLYL | 306 | P02790 | |
| FELSYKSAILNEWTL | 176 | Q9Y4G2 | |
| DLSRETSIWKDIQYA | 341 | Q5T7P8 | |
| SGRNLSDFWEIEEKY | 196 | C9JL84 | |
| RSKSTEFYSELWFIV | 5031 | O75445 | |
| DKEVTLEYVSSLDFW | 526 | P78332 | |
| QWVSYTIDFKDILER | 596 | Q99523 | |
| KVLRSNSLLESTDYW | 46 | Q2M3C7 | |
| KETRYSYNTEWRSEI | 141 | Q9BTV4 | |
| NATLWYKIFTTARDA | 211 | Q9NWD8 | |
| VASLAREVYTEWKTF | 96 | Q96MN5 | |
| RSALYDDIDKAVFAW | 71 | Q17RP2 | |
| FWYQQALKASDRIED | 246 | Q9GZN6 | |
| YRKKWDSNVIETFDI | 91 | Q9Y365 | |
| IRITFDSWKNYTDVD | 186 | Q9UQK1 | |
| VAFLEDKLLWQDSRY | 266 | Q9BYD3 | |
| RRDVDYSDALTEKQW | 1311 | P51531 | |
| YSDALTEKQWLRAIE | 1316 | P51531 | |
| GVDDRSWVFTYAQRK | 116 | Q8WW59 | |
| DDYSRFEDWLKSSER | 8006 | Q8NF91 | |
| TWNVDSELANKLYER | 531 | A2VDJ0 | |
| FLDDYSRFEDWLKSA | 6141 | Q8WXH0 | |
| DSTIRQWFEYLTTFV | 361 | Q969Y0 | |
| INEEWISDKTRFAYD | 281 | P28331 | |
| SKIWNEAVSYRLETY | 536 | Q9H0K6 | |
| LESAFSIKWTDEYES | 196 | Q9NVN3 | |
| DYTKVDRSYEELQWL | 896 | Q6P1X5 | |
| FKDAERTKLFWISYS | 91 | P08709 | |
| SSAAWDETLLDKFYI | 96 | P05015 | |
| RDSDYNLLKAETTFW | 1486 | Q5QGS0 | |
| VKDSDAVYVWIVRSS | 321 | Q9NTG1 | |
| LFTVLDENKSWYSNA | 581 | Q9BQS7 | |
| FYLIVATAEIQDWAK | 446 | Q14916 | |
| TLWALLNSEYVTEEK | 2121 | P58107 | |
| SVSVWELLFYREVSE | 2451 | P58107 | |
| QSVSVWELLFYREVS | 2986 | P58107 | |
| QSVSVWELLFYREVS | 4051 | P58107 | |
| SVSVWELLFYREVSE | 4586 | P58107 | |
| YEESSRDASRKWLEQ | 1356 | Q8TCU6 | |
| FQAELWIKELTSVYD | 336 | Q9P0U3 | |
| WIKELTSVYDSRARE | 341 | Q9P0U3 | |
| KALWESRSQTSYESI | 96 | Q9P2F8 | |
| EYSWVKANLSEVLVS | 66 | Q6IA17 | |
| FIDSSLYKDVILVAW | 356 | Q96JF0 | |
| TVSVNDKTQWRYSYD | 2161 | Q9UKZ4 | |
| TAFRGSLLSWYDQEK | 91 | Q9UIF7 | |
| SYRDWEEIVKTFEIS | 356 | Q9NXX6 | |
| DYRAATQFWRSKVLE | 426 | P13667 | |
| SRLGRWIDFDNDYKT | 136 | P41252 | |
| ESVKEYDSISRLDQW | 261 | P54920 | |
| DDYNWTFRFTGRVIK | 146 | Q9NUV7 | |
| LEAYIRWNKDFGDTT | 601 | Q9UBP0 | |
| TLSRIYVENDFSWDK | 181 | P08514 | |
| EAANYRVFSQKSDVW | 396 | Q9H3Y6 | |
| QDTSKFWYKADISRE | 1166 | Q68CZ2 | |
| SLASRDKNWFYKEDV | 181 | Q8IXM7 | |
| EYLNSLFEELKSWRD | 371 | Q6NSI8 | |
| DEEIVYAKSTALQTW | 41 | Q9Y5B9 | |
| AAFSARWAQEAYKKE | 36 | P12755 | |
| LSDFLYQTGDRITWD | 61 | P59095 | |
| WTYDRTEIDLVLKSE | 176 | P17787 | |
| SERADWQYSSREKDA | 51 | Q5VST6 | |
| ESKLRYIQNFKWTDT | 81 | Q5VW32 | |
| WNYRDTFFNLSLKEV | 211 | Q9NY97 | |
| LESWLTSYKSNEDLF | 1596 | Q13023 | |
| LRVTLSIYADFTWND | 1196 | Q8N3C0 | |
| WEDLEEYQALTFLTR | 11 | A0PJX0 | |
| YFPLTDNKTWAESER | 96 | Q8WXI8 | |
| DWALRQEISTFYTRE | 381 | Q9NRU3 | |
| ATSDWAIELDRTDYK | 166 | Q8WZ69 | |
| DNRIISSKYTVWNFV | 41 | Q9Y2G3 | |
| NYETQTFSSKTEWRV | 2061 | Q6P2Q9 | |
| EVKDITDSYDANWFL | 251 | Q8N1K5 | |
| FWKNLTVLDAIYEVS | 356 | Q4W5G0 | |
| FYIQKSEWERHSESV | 371 | A6NCW0 | |
| EYFIKFWTNELTDTR | 191 | Q5W0Z9 | |
| IAASYDKTVRAWDLE | 161 | Q6ZMY6 | |
| FYIQKSEWERHSESV | 371 | A6NCW7 | |
| LTQYKESEDAELLWR | 106 | Q96DB5 | |
| KVWNVAENSYVETLF | 266 | O43818 | |
| DSTQLSRKFISDYLW | 176 | Q8NBT2 | |
| SRKFISDYLWSLVDT | 181 | Q8NBT2 | |
| YTRVWDFIPDNSKAA | 61 | A6NFA1 | |
| EIQWISNRYLDFSSK | 176 | P23942 | |
| DETLYKAWSSIVYQL | 166 | Q7L523 | |
| DSWDLDFYTKRFQEL | 196 | O15067 | |
| FYIQKSEWERHSESV | 371 | D6R9N7 | |
| QDYIKSYLEQASRIW | 461 | P14679 | |
| RWTKYSLEDVTEVSE | 161 | Q9Y5U2 | |
| FYIQKSEWERHSESV | 371 | A8MUK1 | |
| LADRVYTSKSDVWSF | 721 | P30530 | |
| FYIQKSEWERHSESV | 371 | D6R901 | |
| FYIQKSEWERHSESV | 371 | C9JLJ4 | |
| FYIQKSEWERHSESV | 371 | D6RCP7 | |
| ELTRAYQFDIAKQTW | 1171 | Q9HCK4 | |
| FYIQKSEWERHSESV | 371 | Q7RTZ2 | |
| RKDSFWLYFSQEQEI | 101 | O75310 | |
| KRRNTSVDENYEWDS | 1076 | Q9P2J2 | |
| FFYWTDQNKETELLD | 51 | Q9NQ66 | |
| YLSQGERFIKWDDET | 16 | Q00722 | |
| YVSREWLNKFNTFAE | 711 | Q9Y2K6 | |
| EEASYLRFRNSIWKN | 86 | Q6P444 | |
| EYLFQAQWTVLKSTD | 151 | Q9H0C1 | |
| FYIQKSEWERHSESV | 371 | C9JPN9 | |
| YVLTVSFKWNASTER | 201 | Q9H330 | |
| YSVSFEEDDKIRWAS | 271 | Q99805 | |
| TSYNLEYSSLREEWK | 116 | Q96NI8 | |
| FYIQKSEWERHSESV | 371 | Q0WX57 | |
| DEWQLLDSTQKYLYR | 26 | P17031 | |
| FYIQKSEWERHSESV | 371 | P0C7H9 | |
| FYIQKSEWERHSESV | 371 | P0C7I0 | |
| TWEEFSRAAEKLYLA | 6 | P49458 | |
| LEYLETRDWQEAFFT | 256 | Q8TBZ6 | |
| AYLSYERAKEIWEIT | 281 | O15482 | |
| TFNSYRKEWEELFVN | 51 | Q92609 | |
| GREYKFDVSSELLEW | 2246 | Q70CQ2 | |
| WGTDTYRESIKDLAD | 756 | Q14139 | |
| FYIQKSEWERHSESV | 371 | Q6QN14 | |
| EEWILTGSYDKTSRI | 111 | Q9GZL7 | |
| FSIEKNSYRKTAEWL | 631 | P48553 | |
| DIIIADYDNKWVSIF | 546 | Q9C040 | |
| EFFQTKYDWDLLAAR | 716 | Q15029 | |
| RTDERLNWIYYKDQT | 156 | O15537 | |
| EYLDSSRVEVWEKTS | 121 | Q86XD8 | |
| FYIQKSEWERHSESV | 371 | D6RA61 | |
| VRQWKTNDDTIDFDY | 221 | P49788 | |
| FYIQKSEWERHSESV | 371 | C9J2P7 | |
| FYIQKSEWERHSESV | 371 | D6RBQ6 | |
| WQLESEADARQSKVY | 706 | Q07283 | |
| VSDILFKIWDSFLYE | 841 | Q9UPU7 | |
| IKVWFSDYFNISDTI | 916 | Q96QT4 | |
| VDIAVYFSEDEWKNL | 201 | Q9UDV7 | |
| FYIQKSEWERHSESV | 371 | Q6R6M4 | |
| FYIQKSEWERHSESV | 371 | D6RJB6 | |
| FYIQKSEWERHSESV | 371 | C9JJH3 | |
| EAFLWTTYSNEKIDT | 661 | Q8N7M2 | |
| FYIQKSEWERHSESV | 371 | C9JVI0 | |
| DEEIEKLSTLYWFTV | 391 | P07101 | |
| KQLDVAEFSIYWDVD | 196 | Q5THJ4 | |
| TVWRKDSEILYDVDT | 531 | O94898 | |
| SNLYKEAWDRVKATS | 4701 | P20929 | |
| SVDSEYYNSLKWILE | 751 | Q96PU5 |